APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES

financing of rare disease drugs remains a serious problem for both foreign countries and our country. A limited budget for treatment of such patients determines significant difficulties for its distribution as part of drug supply to rare disease patients. The introduction of multiple-criteria analys...

全面介紹

書目詳細資料

發表在:	Фармакоэкономика
Main Authors:	V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova
格式:	Article
語言:	俄语
出版:	IRBIS LLC 2015-05-01
主題:	rare diseases multiple-criteria decision analysis orphan drugs making decisions
在線閱讀:	https://www.pharmacoeconomics.ru/jour/article/view/88